Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III immunogenicity and reactogenicity study of Fluarix/Influspit SSW 2006/2007 in adults
2006-001918-33Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, single-arm trial of Fluarix in influenza, sponsored by GSK. Primary endpoint: Humoral immune response against each vaccine strain. Started Apr 2006; status: completed.
02
Drugs
Fluarix
03
Conditions
influenza
Beyond the preview
Go deeper on 2006-001918-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001918-33.